4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-010603
EVP, COO, HEAD OF COMMERCIAL sold 2,568 shares at $17.87 ($45,890)
- EVP, COO, HEAD OF COMMERCIAL acquired 5,024 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2024-04-05 | Option exercise | +5,024 | 41,364 | D | ||
| Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2024-04-08 | Sale | −2,568 | $17.87 | $45,890 | 38,796 | D |
| Derivatives | |||||||
| Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2024-04-05 | Option exercise · Restricted Stock Units | −5,024 | 10,048 | D | ||
| Open-market sales · 2,568 sh · avg $17.87 · $45,890 | |||||||
Loading xslF345X05/form4-04092024_060407.xml…